GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Physiomics PLC (LSE:PYC) » Definitions » Construction In Progress

Physiomics (LSE:PYC) Construction In Progress : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Physiomics Construction In Progress?


Physiomics Construction In Progress Historical Data

The historical data trend for Physiomics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Physiomics Construction In Progress Chart

Physiomics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Physiomics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Physiomics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Physiomics (LSE:PYC) Business Description

Traded in Other Exchanges
Address
140 Eastern Avenue, Bee House, Milton Park, Oxfordshire, GBR, OX14 4SB
Physiomics PLC is a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses to transform oncology drug development. The company operates in the UK, European Union Switzerland and USA.

Physiomics (LSE:PYC) Headlines

No Headlines